Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Nov;52(5):801–803. doi: 10.1038/bjc.1985.262

Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.

A Panucci, C Fabris, G Del Favero, D Basso, L Marchioro, A Piccoli, A Burlina, R Naccarato
PMCID: PMC1977229  PMID: 4063154

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banwo O., Versey J., Hobbs J. R. New oncofetal antigen for human pancreas. Lancet. 1974 Apr;1(7859):643–645. doi: 10.1016/s0140-6736(74)93197-3. [DOI] [PubMed] [Google Scholar]
  2. Björklund B. Tissue polypeptide antigen (TPA): Biology, biochemistry, improved assay methodology, clinical significance in cancer and other conditions, and future outlook. Antibiot Chemother (1971) 1978;22:16–31. [PubMed] [Google Scholar]
  3. Cubilla A., Fitzgerald P. J. Pancreas cancer. I. Duct adenocarcinoma. A clinical-pathologic study of 380 patients. Pathol Annu. 1978;13(Pt 1):241–289. [PubMed] [Google Scholar]
  4. Fabris C., Farini R., del Favero G., Piccoli A., Naccarato R. "Plasma"-type ribonuclease in pancreatic cancer diagnosis: a critical appraisal. Hepatogastroenterology. 1981 Dec;28(6):316–318. [PubMed] [Google Scholar]
  5. Farini R., Fabris C., Bonvicini P., Piccoli A., del Favero G., Venturini R., Panucci A., Naccarato R. CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis. Eur J Cancer Clin Oncol. 1985 Apr;21(4):429–432. doi: 10.1016/0277-5379(85)90032-x. [DOI] [PubMed] [Google Scholar]
  6. Kalser M. H., Barkin J. S., Redlhammer D., Heal A. Circulating carcinoembryonic antigen in pancreatic carcinoma. Cancer. 1978 Sep;42(3 Suppl):1468–1471. doi: 10.1002/1097-0142(197809)42:3+<1468::aid-cncr2820420816>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Menendez-Botet C. J., Oettgen H. F., Pinsky C. M., Schwartz M. K. A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms. Clin Chem. 1978 Jun;24(6):868–872. [PubMed] [Google Scholar]
  8. Nitti D., Fabris C., Del Favero G., Farini R., Grassi F., Farini A., Baccaglini U., Pedrazzoli S., Piccoli A., Lise M. Serum ferritin in pancreatic disease. An accurate test of malignancy? Digestion. 1982;25(4):258–262. doi: 10.1159/000198842. [DOI] [PubMed] [Google Scholar]
  9. Panucci A., De Silvestro G., Fabris C., Farini R., Piccoli A., Del Favero G., Baccaglini U., Ceriotti G., Naccarato R. Serum tissue polypeptide antigen in chronic pancreatic disease. Does hepatic damage have any influence? Ric Clin Lab. 1984 Jul-Sep;14(3):425–429. doi: 10.1007/BF02904866. [DOI] [PubMed] [Google Scholar]
  10. Reddi K. K., Holland J. F. Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2308–2310. doi: 10.1073/pnas.73.7.2308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Savarino V., Mansi C., Pugliese V., Ferrara G. B., Arcuri V., Celle G. Evaluation of a new tumor-associated antigen in pancreatic cancer. Digestion. 1984;29(1):1–4. doi: 10.1159/000199000. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES